English · By MundoGood · Sources checked October 12, 2026
AI-generated conceptual illustration; not a medical diagnostic image.
Educational information, not a diagnosis or an individual treatment plan. Consult a qualified health professional about symptoms and treatment choices.
Molluscum contagiosum causes small raised bumps that can linger long enough to test a family’s patience. It is a viral skin infection, and in otherwise healthy people the immune system often clears it without a procedure. That makes watchful waiting a legitimate option after the diagnosis is established. Treatment can still be useful when bumps cause substantial discomfort, spread widely, or occur in a sensitive location.
What the bumps look like and how they spread
Typical bumps are smooth, firm, and sometimes pearly, with a small central dip. They may occur in groups and can be accompanied by itchy eczema-like skin. Appearance varies, and other conditions can resemble them. A health professional can usually assess the bumps directly and decide whether any testing is needed.
The virus spreads through skin contact and contaminated shared items. Scratching, picking, or shaving over lesions can move it to another area of the same person’s skin. In adults, genital lesions may be acquired through sexual contact and need assessment. A child’s bumps in a skin fold do not, by themselves, establish a sexual route of transmission. CDC’s clinical overview describes the infection and its usual course.
Can molluscum be cured without treatment?
The infection commonly clears as the immune response develops. Many cases resolve within months, but some persist substantially longer, occasionally years. New bumps may appear while older ones are disappearing. This pattern can feel like constant failure even though the condition remains within its expected course.
Waiting does not mean ignoring discomfort or complications. Agree on what changes should trigger another appointment, especially if eczema is making scratching hard to control. Taking a periodic private photo can help document the overall direction more reliably than counting every bump several times a day. Avoid a promise that the skin will be clear by a holiday or school event.
The NHS guide supports observation for many cases and explains when symptoms or location justify review. A moisturizer may help surrounding dry skin, but comfort care is different from eliminating the virus. Ask before applying an active treatment to sensitive skin.
When treatment becomes worth considering
Treatment may be appropriate for troublesome itch, associated eczema, distressing or extensive lesions, genital involvement, or reduced immunity. The decision should weigh expected benefit against discomfort, irritation, scarring or pigment change, cost, and the burden of repeat visits. Removing visible bumps does not guarantee that no new ones will appear.
Options include clinician-performed procedures and prescription topical medicines. Freezing and curettage can be effective for selected patients but may be painful and are not equally practical for a young child with many bumps. Discuss the goal explicitly: faster clearance, relief of troublesome lesions, or management of a complication may lead to different choices. The AAD treatment overview explains these trade-offs.
Newer medicines and important safety boundaries
US-approved options include clinician-applied cantharidin for eligible patients and prescription berdazimer gel for patients aged one year and older to use at home as directed. Approval, minimum age, and availability differ between countries. These are options to discuss, not a reason everyone needs treatment.
Cantharidin causes blistering and must be applied by a trained healthcare professional using the approved product and safety instructions. Never buy it online for self-application. Avoid picking or attempting to scoop out a bump at home; this can spread infection and cause injury. The FDA’s cantharidin approval information explains the professional-use requirement and risks.
Tell the prescriber about pregnancy or breastfeeding, age, other treatments, and the location of lesions. Some proposed treatments are unsuitable during pregnancy, and irritated or eczematous skin may need a different approach. Keep prescription products away from eyes and mucosal surfaces as directed. Ask about interactions before combining skin medicines; do not add wart acids or essential oils because a product is described as natural.
What research can and cannot establish
An older Cochrane systematic review found limited convincing evidence for many treatments and found that imiquimod did not offer a useful advantage over vehicle for the studied non-genital cases while increasing local reactions. It excluded immunosuppressed patients and sexually transmitted cases. Its findings should not be generalized to every patient, and it predates newer approved therapies.
A subsequent phase 3 randomized berdazimer trial found improved clearance compared with vehicle, with application-site reactions among the trade-offs. A group-level benefit is not a guarantee that one person’s lesions will clear. Comparing separate studies also cannot reliably rank all options against each other.
Everyday life and reducing spread
Avoid scratching, squeezing, or shaving over bumps. Keep personal towels separate and cover exposed lesions when appropriate. Children usually do not need exclusion from school or daycare solely because of molluscum. For swimming, cover visible lesions with watertight dressings and do not share towels or equipment that contacts affected skin. Stay out of swimming pools while there are open sores because they can become infected. CDC guidance for schools and pools supports proportionate precautions.
Arrange medical review for bumps near an eye or the genitals, significant pain, extensive lesions, or reduced immunity. Increasing warmth, pus, spreading redness, or fever may indicate a secondary infection. Some inflammation occurs as lesions resolve, so redness alone does not prove bacteria are present; a clinician can distinguish the possibilities. The aim is comfortable, safe recovery with a plan that fits the person, rather than aggressive treatment of every harmless bump.
Sources and evidence limits
Sources accessed October 12, 2026. Recommendations and product availability vary by country. This article is an editorial synthesis, not a claim of independent clinical review.
- CDC: Clinical overview of molluscum
- NHS: Molluscum contagiosum
- AAD: Molluscum diagnosis and treatment
- FDA: First approved molluscum treatment
- Cochrane systematic review, 2017
- Berdazimer phase 3 randomized clinical trial
- CDC: Schools, daycare and pools
- FDA: Zelsuvmi approval and trial snapshot
Editorial disclosure: AI assisted with research, writing and the conceptual illustration. This is general health information, not personalized medical advice.